Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin melting tablets vs nasal spray in primary enuresis (children 6–12)
IRCT20230902059325N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Mar 2024
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of desmopressin in primary enuresis (PNE) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Efficacy in reducing enuresis episodes and Safety and side effects. Started Mar 2024; status: completed.
02
Drugs
desmopressin
03
Conditions
primary enuresis (PNE)
Beyond the preview
Go deeper on IRCT20230902059325N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230902059325N1.